Improving civilian medical response to chemical or biological terrorist incidents : interim report on current capabilities /
Improving civilian medical response to chemical or biological terrorist incidents : interim report on current capabilities /
Committee on R & D Needs for Improving Civilian Medical Response to Chemical and Biological Terrorism Incidents, Division of Health Science[s] Policy, Institute of Medicine [and] Board on Environmental Studies and Toxicology, Commission on Life Sciences, National Research Council.
- Washington, D.C. : National Academy Press, 1998.
- 1 online resource
Title from caption (viewed Feb. 7, 2002).
Includes bibliographical references.
Improving Civilian Medical Response to Chemical or Biological Terrorist Incidents -- Copyright -- Contents -- Executive Summary -- INTRODUCTION -- CURRENT CIVILIAN CAPABILITIES -- DETECTION -- Detection of Agents in the Environment -- Detection of Agent Exposure in Clinical Samples -- Detection of Covert Exposures of a Population -- PROTECTION -- TREATMENT -- CONCLUSIONS AND RECOMMENDATIONS -- RESEARCH AND DEVELOPMENT NEEDS -- INTERIM RECOMMENDATIONS -- 1 Introduction -- LEGISLATIVE BACKGROUND -- CHARGE TO THE COMMITTEE -- ASSUMPTIONS AND PARAMETERS OF THIS REPORT. 2 Current Civilian Capabilities -- PREINCIDENT INTELLIGENCE -- DETECTION AND MEASUREMENT OF AGENTS IN THE ENVIRONMENT -- Chemical Agents -- Biological Agents -- PERSONAL PROTECTIVE EQUIPMENT (PPE) -- Chemical Agents -- Biological Agents -- SAFE AND EFFECTIVE PATIENT EXTRACTION -- METHODS FOR RECOGNIZING SIGNS AND SYMPTOMS IN VICTIMS/PATIENTS -- DETECTION AND MEASUREMENT OF AGENT EXPOSURE IN CLINICAL SAMPLES FROM PATIENTS -- Chemical Agents -- Nerve Agents -- Vesicants -- Cyanide -- Biological Agents -- METHODS FOR RECOGNIZING COVERT EXPOSURE OF A POPULATION. MASS-CASUALTY TRIAGE TECHNIQUES/PROCEDURES -- METHODS FOR DECONTAMINATING EXPOSED INDIVIDUALS -- Chemical Agents -- Biological Agents -- AVAILABILITY, SAFETY, AND EFFICACY OF DRUGS AND OTHER THERAPIES -- Chemical Agents -- Nerve Agents -- Vesicants -- Cyanide -- Biological Agents -- Anthrax -- Brucellosis -- Pneumonic Plague -- Q Fever -- Tularemia -- Smallpox -- Viral Encephalitides -- Viral Hemorrhagic Fevers -- Botulinum Toxins -- Staphylococcal enterotoxin B (SEB) -- Ricin -- T-2 Mycotoxin -- PREVENTION, ASSESSMENT, AND TREATMENT OF PSYCHOLOGICAL EFFECTS -- 3 Conclusions and Recommendations. RESEARCH AND DEVELOPMENT NEEDS -- INTERIM RECOMMENDATIONS -- References -- APPENDIX A Committee Biographies -- APPENDIX B Committee Meeting Agenda -- APPENDIX C Table of Lethal and Incapacitating Chemical Weapons -- APPENDIX D Centers for Disease Control and Prevention List of Restricted Agents -- VIRUSES -- BACTERIA -- RICKETTSIAE -- FUNGI -- TOXINS -- APPENDIX E Excerpts from the Metropolitan Medical Strike Team Operational System Description -- METROPOLITAN MEDICAL STRIKE TEAM -- MISSION, CONCEPT OF OPERATIONS, AND TEAM ORGANIZATION -- METROPOLITAN MEDICAL STRIKE TEAM -- TEAM ACTIVATION. I. INTRODUCTION -- IV. FIELD OPERATIONS GUIDE -- APPENDIX F Excerpts from the National Disaster Medical System Home Page -- OFFICIAL FACT SHEETS FROM NDMS -- DMAT / NDMS / other related links -- NDMS PARTNERS -- THE PURPOSE OF THE NATIONAL DISASTER MEDICAL SYSTEM -- Major Components of NDMS include -- NDMS LEAD ORGANIZATIONS -- THE NDMS DISASTER MEDICAL ASSISTANCE TEAMS -- NDMS STATISTICS -- WHAT IS A DISASTER MORTUARY TEAM (DMORT)? -- WHAT IS A VETERINARY MEDICAL ASSISTANCE TEAM (VMAT)? -- APPENDIX G Military Detection and Monitoring Equipment.
This interim report focuses on current civilian capabilities rather than ongoing and planned research and development (R & D) programs, which will be addressed in the committee's final report. The interim report thus provides a baseline against which to evaluate the utility of technology and R & D programs. It identifies some general areas in which innovative R & D is clearly needed, and in some cases already underway. Assessment of this work and its applicability to coping with domestic terrorism with constitute the second half of this study and be the focus of the final report.
0309583942 9780309583947
101133831 DNLM
Chemical warfare--Health aspects.
Terrorism--Government policy--United States.
Civil defense.
Biological warfare.
Chemical agents (Munitions)
Emergency management.
Chemical warfare.
Bioterrorism.
Biological Warfare
Chemical Warfare
Bioterrorism
Civil Defense
Disaster Planning
Chemical Warfare Agents
Terrorisme--Politique gouvernementale--États-Unis.
Protection civile.
Guerre biologique.
Agents chimiques (Munitions)
Guerre chimique.
Bioterrorisme.
Gestion des situations d'urgence.
disaster planning.
POLITICAL SCIENCE--Political Freedom & Security--Law Enforcement.
Biological warfare.
Chemical agents (Munitions)
Chemical warfare--Health aspects.
Civil defense.
Emergency management.
Terrorism--Government policy.
United States
United States.
Electronic books.
Electronic books.
Computer network resources.
Electronic books.
RA648 / .I57 1998eb
363.35
UA 927
Title from caption (viewed Feb. 7, 2002).
Includes bibliographical references.
Improving Civilian Medical Response to Chemical or Biological Terrorist Incidents -- Copyright -- Contents -- Executive Summary -- INTRODUCTION -- CURRENT CIVILIAN CAPABILITIES -- DETECTION -- Detection of Agents in the Environment -- Detection of Agent Exposure in Clinical Samples -- Detection of Covert Exposures of a Population -- PROTECTION -- TREATMENT -- CONCLUSIONS AND RECOMMENDATIONS -- RESEARCH AND DEVELOPMENT NEEDS -- INTERIM RECOMMENDATIONS -- 1 Introduction -- LEGISLATIVE BACKGROUND -- CHARGE TO THE COMMITTEE -- ASSUMPTIONS AND PARAMETERS OF THIS REPORT. 2 Current Civilian Capabilities -- PREINCIDENT INTELLIGENCE -- DETECTION AND MEASUREMENT OF AGENTS IN THE ENVIRONMENT -- Chemical Agents -- Biological Agents -- PERSONAL PROTECTIVE EQUIPMENT (PPE) -- Chemical Agents -- Biological Agents -- SAFE AND EFFECTIVE PATIENT EXTRACTION -- METHODS FOR RECOGNIZING SIGNS AND SYMPTOMS IN VICTIMS/PATIENTS -- DETECTION AND MEASUREMENT OF AGENT EXPOSURE IN CLINICAL SAMPLES FROM PATIENTS -- Chemical Agents -- Nerve Agents -- Vesicants -- Cyanide -- Biological Agents -- METHODS FOR RECOGNIZING COVERT EXPOSURE OF A POPULATION. MASS-CASUALTY TRIAGE TECHNIQUES/PROCEDURES -- METHODS FOR DECONTAMINATING EXPOSED INDIVIDUALS -- Chemical Agents -- Biological Agents -- AVAILABILITY, SAFETY, AND EFFICACY OF DRUGS AND OTHER THERAPIES -- Chemical Agents -- Nerve Agents -- Vesicants -- Cyanide -- Biological Agents -- Anthrax -- Brucellosis -- Pneumonic Plague -- Q Fever -- Tularemia -- Smallpox -- Viral Encephalitides -- Viral Hemorrhagic Fevers -- Botulinum Toxins -- Staphylococcal enterotoxin B (SEB) -- Ricin -- T-2 Mycotoxin -- PREVENTION, ASSESSMENT, AND TREATMENT OF PSYCHOLOGICAL EFFECTS -- 3 Conclusions and Recommendations. RESEARCH AND DEVELOPMENT NEEDS -- INTERIM RECOMMENDATIONS -- References -- APPENDIX A Committee Biographies -- APPENDIX B Committee Meeting Agenda -- APPENDIX C Table of Lethal and Incapacitating Chemical Weapons -- APPENDIX D Centers for Disease Control and Prevention List of Restricted Agents -- VIRUSES -- BACTERIA -- RICKETTSIAE -- FUNGI -- TOXINS -- APPENDIX E Excerpts from the Metropolitan Medical Strike Team Operational System Description -- METROPOLITAN MEDICAL STRIKE TEAM -- MISSION, CONCEPT OF OPERATIONS, AND TEAM ORGANIZATION -- METROPOLITAN MEDICAL STRIKE TEAM -- TEAM ACTIVATION. I. INTRODUCTION -- IV. FIELD OPERATIONS GUIDE -- APPENDIX F Excerpts from the National Disaster Medical System Home Page -- OFFICIAL FACT SHEETS FROM NDMS -- DMAT / NDMS / other related links -- NDMS PARTNERS -- THE PURPOSE OF THE NATIONAL DISASTER MEDICAL SYSTEM -- Major Components of NDMS include -- NDMS LEAD ORGANIZATIONS -- THE NDMS DISASTER MEDICAL ASSISTANCE TEAMS -- NDMS STATISTICS -- WHAT IS A DISASTER MORTUARY TEAM (DMORT)? -- WHAT IS A VETERINARY MEDICAL ASSISTANCE TEAM (VMAT)? -- APPENDIX G Military Detection and Monitoring Equipment.
This interim report focuses on current civilian capabilities rather than ongoing and planned research and development (R & D) programs, which will be addressed in the committee's final report. The interim report thus provides a baseline against which to evaluate the utility of technology and R & D programs. It identifies some general areas in which innovative R & D is clearly needed, and in some cases already underway. Assessment of this work and its applicability to coping with domestic terrorism with constitute the second half of this study and be the focus of the final report.
0309583942 9780309583947
101133831 DNLM
Chemical warfare--Health aspects.
Terrorism--Government policy--United States.
Civil defense.
Biological warfare.
Chemical agents (Munitions)
Emergency management.
Chemical warfare.
Bioterrorism.
Biological Warfare
Chemical Warfare
Bioterrorism
Civil Defense
Disaster Planning
Chemical Warfare Agents
Terrorisme--Politique gouvernementale--États-Unis.
Protection civile.
Guerre biologique.
Agents chimiques (Munitions)
Guerre chimique.
Bioterrorisme.
Gestion des situations d'urgence.
disaster planning.
POLITICAL SCIENCE--Political Freedom & Security--Law Enforcement.
Biological warfare.
Chemical agents (Munitions)
Chemical warfare--Health aspects.
Civil defense.
Emergency management.
Terrorism--Government policy.
United States
United States.
Electronic books.
Electronic books.
Computer network resources.
Electronic books.
RA648 / .I57 1998eb
363.35
UA 927